23rd European Meeting on HIV & Hepatitis 2025
Show local (UTC) times
14:00
Opening of the Meeting
14:00
Opening Words
14:05
Welcome to Barcelona
Bonaventura Clotet
14:15
Session 1: Implementation of HIV Prevention in Europe
14:15
Chair
Annemarie Wensing
Josep M Llibre
14:15
Efficacy, Toxicity and Adherence Considerations
Juan Ambrosioni
14:30
Logistical and Infrastructure Considerations
Angel Rivero Calaf
14:45
Price Considerations
Valentina Cambiano
15:45
Coffee Break & Poster Viewing 1
16:45
Session 2: Abstract-Driven Session - Virological Control
16:15
#1 #1 Comparable Dynamics of Cell-Associated HIV-RNA, Total and Intact Proviral HIV-1 DNA in Virologically Suppressed People with HIV Switching to 2DR or Continuing 3DR Over an 18-Month Follow-Up
Abstract
Lia Fiaschi
16:25
#2 #2 In Addition to Their Ability to Induce Resistance to Antiretrovirals, Integrase Inhibitors and Lenacapavir Resistance Mutations Enable HIV-1 to Evade Recognition by the Innate Immune System
Abstract
Elisa Teyssou
16:35
#3 #3 Unveiling Novel Microbiome Signatures for Natural Virological Control in HIV-1 Elite Controllers
Abstract
Xiangning Bai
16:45
Chair
Martin Obermeier
Federico García
16:45
#4 #4 WG-am: A Novel Antiviral Dipeptide from Elite Controllers as a Promising Vaginal Microbicide for HIV Prevention
Abstract
Rafael Ceña Diez
17:15
Guided Poster Tour 1
17:15
Chair
Federico García
17:15
#38 Optimizing a HIV-1 Genotypic Resistance Assay for Diverse Subtypes and Illumina Sequencing
Abstract
Jannik Fonager
17:25
#42 Automated Reflex HIV Screening Based on Diagnostic Indicators: A New Perspective from Clinical Microbiology
Abstract
Marta Illescas Lopez
17:35
#64 Selection Rate of Resistance to Long-Acting CAB/RPV in a Real Life French Cohort with Strict Inclusion and Monitoring Criteria
Abstract
Sidonie Lambert
17:45
#66 HBV Reactivation Post-Switch to HBV-Inactive ART: A Scoping Review
Abstract
Anna Maria Geretti
17:55
#68 Add-On Efficacy of Doravirine to Antiretroviral Treatment in People Living with HIV-1 Harboring a Classical Virological Failure and Those with Persistent Low-Level Viremia
Abstract
Vincent Calvez
18:05
#70 Very Slow Decay of Total HIV-1 DNA During Suppressive ART: A Routine Cohort Report
Abstract